Info
Management- Stages I–II of Management of follicular lymphoma
- ISRT alone results
- in 10-y RFS of ~40% w/ Stage I pts faring better than Stage II (JCO 1996;14:1282).
- The current recommended dose is 2400 cGy
- Observation in selected cases where ISRT may result in significant morbidity w/ systemic being employed when indicated by NCCN/GELF criteria, as for Stages III–IV